Literature DB >> 18467699

Deleterious effects of plasminogen activators in neonatal cerebral hypoxia-ischemia.

Faisal Adhami1, Dan Yu, Wei Yin, Aryn Schloemer, Kevin A Burns, Guanghong Liao, Jay L Degen, Jun Chen, Chia-Yi Kuan.   

Abstract

The immature brains of newborns often respond differently from the brains of adults when exposed to similar insults. Previous studies have indicated that although hypoxia-ischemia (HI) induces persistent thrombosis in adult brains, it only modestly impairs blood perfusion in newborn brains. Here, we used the Vannucci model of HI encephalopathy to study age-related responses to cerebral HI in rat pups. We found that HI triggered fibrin deposition and impaired blood perfusion in both neonatal and adult brains. However, these effects were only transient in neonatal brains (<4 hours) and were accompanied by acute induction of both tissue-type and urinary-type plasminogen activators (tPA and uPA), which was not observed in adult brains subjected to the same insult. Interestingly, activation of the plasminogen system persisted up to 24 hours in neonatal brains, long after the clearance of fibrin-rich thrombi. Furthermore, astrocytes and macrophages outside blood vessels expressed tPA after HI, suggesting the possibility of tPA/plasmin-mediated cytotoxicity. Consistent with this hypothesis, injection of alpha2-antiplasmin into cerebral ventricles markedly ameliorated HI-induced damage to neurofilaments and white matter oligodendrocytes, providing a dose-response reduction of brain injury after 7 days of recovery. Conversely, ventricular injection of tPA increased HI-induced brain damage. Together, these results suggest that tPA/plasmin induction, which may contribute to acute fibrinolysis, is a critical component of extravascular proteolytic damage in immature brains, representing a new therapeutic target for the treatment of HI encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467699      PMCID: PMC2408429          DOI: 10.2353/ajpath.2008.070979

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

Review 1.  Neonatal brain injury.

Authors:  Donna M Ferriero
Journal:  N Engl J Med       Date:  2004-11-04       Impact factor: 91.245

2.  Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice.

Authors:  Y F Wang; S E Tsirka; S Strickland; P E Stieg; S G Soriano; S A Lipton
Journal:  Nat Med       Date:  1998-02       Impact factor: 53.440

3.  Proteolytic cascade enzymes increase in focal cerebral ischemia in rat.

Authors:  G A Rosenberg; M Navratil; F Barone; G Feuerstein
Journal:  J Cereb Blood Flow Metab       Date:  1996-05       Impact factor: 6.200

4.  Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice.

Authors:  M Y Ahn; Z G Zhang; W Tsang; M Chopp
Journal:  Brain Res       Date:  1999-08-07       Impact factor: 3.252

Review 5.  Tissue plasminogen activator in central nervous system physiology and pathology.

Authors:  Jerry P Melchor; Sidney Strickland
Journal:  Thromb Haemost       Date:  2005-04       Impact factor: 5.249

6.  Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.

Authors:  Kiyoshi Tsuji; Toshiaki Aoki; Emiri Tejima; Ken Arai; Sun-Ryung Lee; Dmitriy N Atochin; Paul L Huang; Xiaoying Wang; Joan Montaner; Eng H Lo
Journal:  Stroke       Date:  2005-07-28       Impact factor: 7.914

7.  2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo.

Authors:  Géraldine Liot; Karim Benchenane; Frédéric Léveillé; José P López-Atalaya; Mónica Fernández-Monreal; Antonio Ruocco; Eric T Mackenzie; Alain Buisson; Carine Ali; Denis Vivien
Journal:  J Cereb Blood Flow Metab       Date:  2004-10       Impact factor: 6.200

8.  Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C.

Authors:  Dong Liu; Tong Cheng; Huang Guo; José A Fernández; John H Griffin; Xiaomei Song; Berislav V Zlokovic
Journal:  Nat Med       Date:  2004-10-31       Impact factor: 53.440

9.  Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.

Authors:  N Nagai; M De Mol; H R Lijnen; P Carmeliet; D Collen
Journal:  Circulation       Date:  1999-05-11       Impact factor: 29.690

10.  Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator.

Authors:  S E Tsirka; A Gualandris; D G Amaral; S Strickland
Journal:  Nature       Date:  1995-09-28       Impact factor: 49.962

View more
  17 in total

1.  Orchestration of the crosstalk between astrocytes and cancer cells affects the treatment and prognosis of lung cancer sufferers with brain metastasis.

Authors:  Wangshu Dai; Hongcheng Zhu; Guangzong Chen; Hao Gu; Yihang Gu; Xinchen Sun; Xiaoning Zeng
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

2.  Tissue Plasminogen Activator Expression Is Restricted to Subsets of Excitatory Pyramidal Glutamatergic Neurons.

Authors:  Morgane Louessard; Alexandre Lacroix; Magalie Martineau; Gregoire Mondielli; Axel Montagne; Flavie Lesept; Bertrand Lambolez; Bruno Cauli; Jean-Pierre Mothet; Denis Vivien; Eric Maubert
Journal:  Mol Neurobiol       Date:  2015-09-16       Impact factor: 5.590

3.  Prenatal stress alters hippocampal synaptic plasticity in young rat offspring through preventing the proteolytic conversion of pro-brain-derived neurotrophic factor (BDNF) to mature BDNF.

Authors:  Che-Ming Yeh; Chiung-Chun Huang; Kuei-Sen Hsu
Journal:  J Physiol       Date:  2011-12-12       Impact factor: 5.182

4.  Plasminogen activator inhibitor-1 mitigates brain injury in a rat model of infection-sensitized neonatal hypoxia-ischemia.

Authors:  Dianer Yang; Yu-Yo Sun; Niza Nemkul; Jessica M Baumann; Ahmed Shereen; R Scott Dunn; Marsha Wills-Karp; Daniel A Lawrence; Diana M Lindquist; Chia-Yi Kuan
Journal:  Cereb Cortex       Date:  2012-05-03       Impact factor: 5.357

5.  Omega-3 polyunsaturated fatty acid supplementation confers long-term neuroprotection against neonatal hypoxic-ischemic brain injury through anti-inflammatory actions.

Authors:  Wenting Zhang; Xiaoming Hu; Wei Yang; Yanqin Gao; Jun Chen
Journal:  Stroke       Date:  2010-08-12       Impact factor: 7.914

6.  Serpins promote cancer cell survival and vascular co-option in brain metastasis.

Authors:  Manuel Valiente; Anna C Obenauf; Xin Jin; Qing Chen; Xiang H-F Zhang; Derek J Lee; Jamie E Chaft; Mark G Kris; Jason T Huse; Edi Brogi; Joan Massagué
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

7.  Monocytic Infiltrates Contribute to Autistic-like Behaviors in a Two-Hit Model of Neurodevelopmental Defects.

Authors:  Hong-Ru Chen; Ching-Wen Chen; Nandita Mandhani; Jonah C Short-Miller; Marchelle R Smucker; Yu-Yo Sun; Chia-Yi Kuan
Journal:  J Neurosci       Date:  2020-10-30       Impact factor: 6.167

Review 8.  Effects of integrins and integrin αvβ3 inhibitor on angiogenesis in cerebral ischemic stroke.

Authors:  Jia-Jia Bi; Li Yi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

9.  Intranasal delivery of cell-penetrating anti-NF-κB peptides (Tat-NBD) alleviates infection-sensitized hypoxic-ischemic brain injury.

Authors:  Dianer Yang; Yu-Yo Sun; Xiaoyi Lin; Jessica M Baumann; R Scott Dunn; Diana M Lindquist; Chia-Yi Kuan
Journal:  Exp Neurol       Date:  2013-01-23       Impact factor: 5.330

10.  Therapeutic administration of plasminogen activator inhibitor-1 prevents hypoxic-ischemic brain injury in newborns.

Authors:  Dianer Yang; Niza Nemkul; Ahmed Shereen; Alice Jone; R Scott Dunn; Daniel A Lawrence; Diana Lindquist; Chia-Yi Kuan
Journal:  J Neurosci       Date:  2009-07-08       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.